
Cellectar reporting favorable results from clinical trial
Cellectar Biosciences is reporting patients in a recent clinical trial of its cancer therapy medication are surviving longer. The first four study groups of the Madison company’s ongoing Phase 1 clinical trial included 15 patients who had been previously